Thomas Albert Engler

Person

Indianapolis, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors
- Patent number 9,624,218
- Issue date Apr 18, 2017
- Eli Lilly and Company
- Marcio Chedid
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1...
- Patent number 8,648,063
- Issue date Feb 11, 2014
- Eli Lilly and Company
- Marcio Chedid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1...
- Patent number 8,318,713
- Issue date Nov 27, 2012
- Eli Lilly and Company
- Marcio Chedid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purine derivatives as kinase inhibitors
- Patent number 8,058,425
- Issue date Nov 15, 2011
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives as kinase inhibitors
- Patent number 8,022,065
- Issue date Sep 20, 2011
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-β inhibitors
- Patent number 7,511,056
- Issue date Mar 31, 2009
- Eli Lilly and Company
- Clive Gideon Diefenbacher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives as kinase inhibitors
- Patent number 7,491,716
- Issue date Feb 17, 2009
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors
- Patent number 7,405,305
- Issue date Jul 29, 2008
- Eli Lilly and Company
- Pamela Ann Albaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as pharmaceutical agents
- Patent number 7,405,299
- Issue date Jul 29, 2008
- Eli Lilly and Company
- Douglas Wade Beight
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compounds for treating proliferative diseases
- Patent number 7,109,229
- Issue date Sep 19, 2006
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PYRIDO[2,3-d]PYRIMIDIN-4-ONE COMPOUNDS AS TANKYRASE INHIBITORS
- Publication number 20160251348
- Publication date Sep 1, 2016
- Eli Lilly and Company
- Marcio CHEDID
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POTENTIATION OF CANCER CHEMOTHERAPY BY 7-(2, 5- DIHYDRO- 4-IMIDAZO...
- Publication number 20130039996
- Publication date Feb 14, 2013
- Eli Lilly and Company
- Aktham Aburub
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PURINE DERIVATIVES AS KINASE INHIBITORS
- Publication number 20110294792
- Publication date Dec 1, 2011
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PURINE DERIVATIVES AS KINASE INHIBITORS
- Publication number 20110207721
- Publication date Aug 25, 2011
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POTENTIATION OF CANCER CHEMOTHERAPY BY 7-(2, 5- DIHYDRO- 4-IMIDAZO...
- Publication number 20100166884
- Publication date Jul 1, 2010
- Aktham Aburub
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PURINE DERIVATIVES AS KINASE INHIBITORS
- Publication number 20090105229
- Publication date Apr 23, 2009
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tgf-Beta Inhibitors
- Publication number 20080262004
- Publication date Oct 23, 2008
- Eli Lilly and Company
- Clive Gideon Diefenbacher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds as pharmaceutical agents
- Publication number 20060058295
- Publication date Mar 16, 2006
- Eli Lilly and Company
- Douglas Wade Beight
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase inhibitors
- Publication number 20050288321
- Publication date Dec 29, 2005
- Pamela Ann Albaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Purine derivatives as kinase inhibitors
- Publication number 20050090483
- Publication date Apr 28, 2005
- Eli Lilly and Company
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods and compounds for treating proliferative diseases
- Publication number 20040048915
- Publication date Mar 11, 2004
- Thomas Albert Engler
- C07 - ORGANIC CHEMISTRY

Thomas Albert Engler

Person

Patents Grantslast 30 patents

Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors

Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1...

Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1...

Purine derivatives as kinase inhibitors

Purine derivatives as kinase inhibitors

TGF-β inhibitors

Purine derivatives as kinase inhibitors

Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors

Compounds as pharmaceutical agents

Methods and compounds for treating proliferative diseases

Patents Applicationslast 30 patents

PYRIDO[2,3-d]PYRIMIDIN-4-ONE COMPOUNDS AS TANKYRASE INHIBITORS

POTENTIATION OF CANCER CHEMOTHERAPY BY 7-(2, 5- DIHYDRO- 4-IMIDAZO...

PURINE DERIVATIVES AS KINASE INHIBITORS

PURINE DERIVATIVES AS KINASE INHIBITORS

POTENTIATION OF CANCER CHEMOTHERAPY BY 7-(2, 5- DIHYDRO- 4-IMIDAZO...

PURINE DERIVATIVES AS KINASE INHIBITORS

Tgf-Beta Inhibitors

Novel compounds as pharmaceutical agents

Kinase inhibitors

Purine derivatives as kinase inhibitors

Methods and compounds for treating proliferative diseases